相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction
Carlos D'Ancona et al.
NEUROUROLOGY AND URODYNAMICS (2019)
Links between lower urinary tract symptoms, intermittent hypoxia and diabetes: Causes or cures?
Lisa L. Abler et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2018)
Tamsulosin Treatment Affecting Patient-reported Outcomes in Benign Prostatic Hyperplasia-associated Depressive Symptoms
Kyu Shik Kim et al.
UROLOGY (2016)
Urgency and other lower urinary tract symptoms in men aged ≥ 40 years: a Belgian epidemiological survey using the ICIQ-MLUTS questionnaire
D. De Ridder et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2015)
Comparative Effectiveness and Safety of Monodrug Therapies for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia A Network Meta-analysis
Jin-Qiu Yuan et al.
MEDICINE (2015)
Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
Joao Silva et al.
CURRENT OPINION IN UROLOGY (2014)
What Is the Most Bothersome Lower Urinary Tract Symptom? Individual- and Population- level Perspectives for Both Men and Women
Arnav Agarwal et al.
EUROPEAN UROLOGY (2014)
Efficacy and tolerability of tamsulosin 0.4 mg in Asian patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia refractory to tamsulosin 0.2 mg: A randomized placebo controlled trial
Jung Jun Kim et al.
INTERNATIONAL JOURNAL OF UROLOGY (2014)
A Survey of the FAERS Database Concerning the Adverse Event Profiles of α1-Adrenoreceptor Blockers for Lower Urinary Tract Symptoms
Koji Yoshimura et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2013)
Male lower urinary tract symptoms and a1D-adrenoceptors
Osamu Ishizuka et al.
INTERNATIONAL JOURNAL OF UROLOGY (2013)
Latest treatment for lower urinary tract dysfunction: Therapeutic agents and mechanism of action
Osamu Yamaguchi
INTERNATIONAL JOURNAL OF UROLOGY (2013)
Comparative rapid onset of efficacy between doxazosin gastrointestinal therapeutic system and tamsulosin in patients with lower urinary tract symptoms from benign prostatic hyperplasia: a multicentre, prospective, randomised study
M. S. Chung et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Outline of JUA clinical guidelines for benign prostatic hyperplasia
Yukio Homma et al.
INTERNATIONAL JOURNAL OF UROLOGY (2011)
Most Bothersome Symptom and Symptom Specific Goal Achievement in Patients With Benign Prostatic Obstruction: A Prospective Open Label Study
Young-Suk Lee et al.
JOURNAL OF UROLOGY (2011)
Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia
Kevin T. McVary et al.
JOURNAL OF UROLOGY (2011)
Effect of Doxazosin Gastrointestinal Therapeutic System 4 mg vs Tamsulosin 0.2 mg on Nocturia in Chinese Men With Lower Urinary Tract Symptoms: A Prospective, Multicenter, Randomized, Open, Parallel Study
Kai Zhang et al.
UROLOGY (2011)
Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men
Sean A. Martin et al.
WORLD JOURNAL OF UROLOGY (2011)
EFFICACY AND SAFETY OF THE DOXAZOSIN GASTROINTESTINAL THERAPEUTIC SYSTEM FOR THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA
Guang-Huan Sun et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2010)
Prevalence and characteristics of lower urinary tract symptoms in men aged ≥80 years
J. Kellogg Parsons et al.
UROLOGY (2008)
Scales to assess the quality of randomized controlled trials: A systematic review
Susan Armijo Olivo et al.
PHYSICAL THERAPY (2008)
Doxazosin gastrointestinal therapeutic system versus tamsulosin for the treatment of benign prostatic hyperplasia: A study in Chinese patients
Zhaoying Xue et al.
INTERNATIONAL JOURNAL OF UROLOGY (2007)
Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample - The Boston Area Community Health (BACH) Survey
Varant Kupelian et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia
Djoko Rahardjo et al.
INTERNATIONAL JOURNAL OF UROLOGY (2006)
A randomised, double-blind study comparing the efficacy and tolerability of controlled-release doxazosin and tamsulosin in the treatment of benign prostatic hyperplasia in Brazil
A. C. L. Pompeo et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Quantification of alpha1-adrenoceptor subtypes by real-time RT-PCR and correlation with age and prostate volume in benign prostatic hyperplasia patients
Y Kojima et al.
PROSTATE (2006)
A double-blind placebo-controlled study evaluating the onset of action of doxazosin gastrointestinal therapeutic system in the treatment of benign prostatic hyperplasia
CG Roehrborn et al.
EUROPEAN UROLOGY (2005)
α1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia
CG Roehrborn et al.
JOURNAL OF UROLOGY (2004)
Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician
CR Chapple
BJU INTERNATIONAL (2004)
Doxazosin controlled release vs tamsulosin in the management of benign prostatic hyperplasia: an efficacy analysis
RS Kirby et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2004)
Role of the newer alpha1-adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms
FC Lowe
CLINICAL THERAPEUTICS (2004)
A randomized, double-blind crossover study of tamsulosin and controlled-release doxazosin in patients with benign prostatic hyperplasia
RS Kirby
BJU INTERNATIONAL (2003)
A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia
RS Kirby et al.
BJU INTERNATIONAL (2001)
alpha(1)-adrenoceptor selectivity and the treatment of benign prostatic hyperplasia and lower urinary tract symptoms
R Kirby et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2000)